Wilmington Savings Fund Society FSB Lowers Holdings in McKesson Corporation $MCK

Wilmington Savings Fund Society FSB decreased its holdings in shares of McKesson Corporation (NYSE:MCK) by 19.2% during the third quarter, according to its most recent filing with the SEC. The firm owned 3,895 shares of the company’s stock after selling 926 shares during the period. Wilmington Savings Fund Society FSB’s holdings in McKesson were worth $3,009,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Sunbelt Securities Inc. boosted its position in McKesson by 3.6% during the 3rd quarter. Sunbelt Securities Inc. now owns 494 shares of the company’s stock valued at $382,000 after acquiring an additional 17 shares in the last quarter. Coldstream Capital Management Inc. lifted its stake in shares of McKesson by 1.3% during the 3rd quarter. Coldstream Capital Management Inc. now owns 3,732 shares of the company’s stock worth $2,883,000 after purchasing an additional 49 shares during the last quarter. Aspire Private Capital LLC boosted its position in McKesson by 19.2% during the third quarter. Aspire Private Capital LLC now owns 1,962 shares of the company’s stock valued at $1,516,000 after purchasing an additional 316 shares in the last quarter. Danica Pension Livsforsikringsaktieselskab purchased a new stake in shares of McKesson during the third quarter valued at about $135,352,000. Finally, Danske Bank A S acquired a new stake in McKesson in the third quarter valued at approximately $127,487,000. 85.07% of the stock is currently owned by institutional investors.

McKesson Trading Down 2.3%

Shares of NYSE:MCK opened at $920.48 on Thursday. The firm has a market cap of $112.75 billion, a price-to-earnings ratio of 26.47, a PEG ratio of 1.52 and a beta of 0.38. The stock’s 50-day moving average price is $900.55 and its two-hundred day moving average price is $830.63. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same period in the prior year, the firm posted $8.03 EPS. The company’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s payout ratio is currently 9.43%.

Insider Buying and Selling at McKesson

In related news, Director Maria Martinez sold 349 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total value of $328,014.63. Following the transaction, the director directly owned 301 shares of the company’s stock, valued at approximately $282,900.87. This trade represents a 53.69% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Leann B. Smith sold 190 shares of the business’s stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president directly owned 2,989 shares of the company’s stock, valued at approximately $2,824,605. This trade represents a 5.98% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 3,868 shares of company stock worth $3,743,820. 0.08% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

MCK has been the subject of a number of recent analyst reports. Mizuho raised their price objective on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Raymond James Financial set a $970.00 price target on McKesson in a research note on Thursday, March 5th. JPMorgan Chase & Co. raised their price target on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Morgan Stanley restated an “overweight” rating and set a $966.00 price target on shares of McKesson in a research note on Thursday, January 29th. Finally, TD Cowen upped their price objective on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $960.93.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.